1033 related articles for article (PubMed ID: 8469345)
21. Diabetes mellitus on the Zambian Copperbelt.
Rolfe M; Armstrong JR
J R Coll Physicians Lond; 1989 Oct; 23(4):255-9. PubMed ID: 2585364
[No Abstract] [Full Text] [Related]
22. Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes.
Spallone V; Maiello MR; Cicconetti E; Menzinger G
Diabetes Res Clin Pract; 1997 Jan; 34(3):169-79. PubMed ID: 9069569
[TBL] [Abstract][Full Text] [Related]
23. Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.
Msanga D; Reis K; Kayange N; Bakalemwa R; Kidenya B; Hau D; Mwanansao C; Mahamba D; Ottaru S; Kwiyolecha E; Peck R
Ann Glob Health; 2020 Apr; 86(1):43. PubMed ID: 32346524
[TBL] [Abstract][Full Text] [Related]
24. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota.
Dwyer MS; Melton LJ; Ballard DJ; Palumbo PJ; Trautmann JC; Chu CP
Diabetes Care; 1985; 8(4):316-22. PubMed ID: 4042796
[TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
26. Abnormal sleep patterns in subjects with type II diabetes mellitus and its effect on diabetic microangiopathies: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 20).
Raman R; Gupta A; Venkatesh K; Kulothungan V; Sharma T
Acta Diabetol; 2012 Aug; 49(4):255-61. PubMed ID: 21113729
[TBL] [Abstract][Full Text] [Related]
27. Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes.
Megallaa MH; Ismail AA; Zeitoun MH; Khalifa MS
Diabetes Metab Syndr; 2019; 13(2):1287-1292. PubMed ID: 31336479
[TBL] [Abstract][Full Text] [Related]
28. Clinical correlates of advanced retinopathy in type II diabetic patients: implications for screening. The CODIAB-INSERM-Zeneca Pharma Study Group.
Delcourt C; Villatte-Cathelineau B; Vauzelle-Kervroedan F; Papoz L
J Clin Epidemiol; 1996 Jun; 49(6):679-85. PubMed ID: 8656230
[TBL] [Abstract][Full Text] [Related]
29. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
Roll U; Nuber A; Schröder A; Gerlach E; Janka HU; Ziegler AG
Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299
[TBL] [Abstract][Full Text] [Related]
30. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy.
Saini DC; Kochar A; Poonia R
Indian J Ophthalmol; 2021 Nov; 69(11):3364-3368. PubMed ID: 34708806
[TBL] [Abstract][Full Text] [Related]
31. Predominant Complications of Type 2 Diabetes in Kumasi: A 4-Year Retrospective Cross-Sectional Study at a Teaching Hospital in Ghana.
Annani-Akollor ME; Addai-Mensah O; Fondjo LA; Sallah L; Owiredu EW; Acheampong E; Akamugri S
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31075814
[No Abstract] [Full Text] [Related]
32. [Type 2 diabetic patients in a population sample from Ribeirão Preto area (São Paulo)].
Foss MC; Paccola GM; de Souza NV; Iazigi N
AMB Rev Assoc Med Bras; 1989; 35(5):179-83. PubMed ID: 2486414
[TBL] [Abstract][Full Text] [Related]
33. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
34. Microvascular complications of NIDDM in Hispanics and non-Hispanic whites. San Luis Valley Diabetes Study.
Hamman RF; Franklin GA; Mayer EJ; Marshall SM; Marshall JA; Baxter J; Kahn LB
Diabetes Care; 1991 Jul; 14(7):655-64. PubMed ID: 1914815
[TBL] [Abstract][Full Text] [Related]
35. [A case from practice (311). Sensorimotor polyneuropathy and autonomous neuropathy with increased sweating in insulin-dependent diabetes mellitus II--diabetic retinopathy, nephropathy and microangiopathy].
Thumshirn M; Berger W
Praxis (Bern 1994); 1994 Nov; 83(45):1272-3. PubMed ID: 7973288
[No Abstract] [Full Text] [Related]
36. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).
Raman R; Gupta A; Krishna S; Kulothungan V; Sharma T
J Diabetes Complications; 2012; 26(2):123-8. PubMed ID: 22446033
[TBL] [Abstract][Full Text] [Related]
37. Presence of anti-DNA antibody in diabetes mellitus: its relation to the duration of diabetes and diabetic complications.
Yokokawa N; Aizawa T; Ishihara M; Koizumi Y; Yanagisawa K; Yamada T
Metabolism; 1989 Sep; 38(9):891-4. PubMed ID: 2671600
[TBL] [Abstract][Full Text] [Related]
38. Non-response bias in studies of diabetic complications: the Rochester Diabetic Neuropathy Study.
Melton LJ; Dyck PJ; Karnes JL; O'Brien PC; Service FJ
J Clin Epidemiol; 1993 Apr; 46(4):341-8. PubMed ID: 8482998
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of overt diabetic nephropathy in patients with noninsulin-dependent diabetes mellitus.
Norymberg C; Shenkman L
Isr J Med Sci; 1991 Mar; 27(3):124-30. PubMed ID: 2016150
[TBL] [Abstract][Full Text] [Related]
40. Microvascular Complications of Type 2 Diabetes Mellitus.
Faselis C; Katsimardou A; Imprialos K; Deligkaris P; Kallistratos M; Dimitriadis K
Curr Vasc Pharmacol; 2020; 18(2):117-124. PubMed ID: 31057114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
